Aduro Biotech Company Profile (NASDAQ:ADRO)

About Aduro Biotech

Aduro Biotech logoAduro Biotech, Inc. is a clinical-stage immunotherapy company. The Company is focused on the discovery, development and commercialization of therapies that transform the treatment of various diseases. The Company has developed approximately three technology platforms, which include Live, Attenuated, Double-Deleted (LADD), Stimulator of Interferon Genes (STING) Pathway Activator and B-select monoclonal antibodies. Its LADD product candidates include CRS-207, ADU-623, ADU-741 and ADU-214. Its STING Activator product candidates include ADU-S100. Its LADD technology platform is engineered to express tumor-associated antigens to induce specific and targeted immune responses. Its STING Pathway Activator platform is designed to activate the intracellular STING receptor, resulting in a tumor-specific immune response. Its B-select monoclonal antibody platform includes various immune modulating assets in research and preclinical development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADRO
  • CUSIP:
Key Metrics:
  • Previous Close: $14.54
  • 50 Day Moving Average: $14.73
  • 200 Day Moving Average: $13.14
  • 52-Week Range: $7.26 - $34.95
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.17
  • P/E Growth: 0.24
  • Market Cap: $865.11M
  • Outstanding Shares: 64,754,000
  • Beta: 3.87
Profitability:
  • Net Margins: -23.69%
  • Return on Equity: -9.23%
  • Return on Assets: -4.87%
Debt:
  • Current Ratio: 10.22%
  • Quick Ratio: 10.22%
Additional Links:
Companies Related to Aduro Biotech:

Analyst Ratings

Consensus Ratings for Aduro Biotech (NASDAQ:ADRO) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $22.00 (66.16% upside)

Analysts' Ratings History for Aduro Biotech (NASDAQ:ADRO)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Canaccord GenuityReiterated RatingBuy$30.00View Rating Details
7/11/2016Roth CapitalReiterated RatingBuy$22.00View Rating Details
6/6/2016FBR & CoReiterated RatingBuyView Rating Details
5/17/2016Leerink SwannReiterated RatingOutperform$48.00 -> $14.00View Rating Details
3/15/2016Bank of America Corp.DowngradeBuy -> Underperform$32.00 -> $14.00View Rating Details
2/2/2016William BlairInitiated CoverageBuyView Rating Details
12/1/2015Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Aduro Biotech (NASDAQ:ADRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/21/2016        
8/3/2016($0.18)$0.03$25.24 million$39.00 millionViewN/AView Earnings Details
5/2/2016Q116($0.25)($0.45)ViewN/AView Earnings Details
3/8/2016Q415($0.15)$0.04$34.38 millionViewN/AView Earnings Details
11/24/2015Q3($0.08)$0.01$15.80 million$19.15 millionViewN/AView Earnings Details
8/10/2015Q215($0.01)($0.50)$1.00 million$9.90 millionViewN/AView Earnings Details
5/28/2015Q115($0.03)($39.97)$9.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aduro Biotech (NASDAQ:ADRO)
Current Year EPS Consensus Estimate: $-1.39 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20168($0.52)($0.10)($0.29)
Q2 20167($0.46)$0.11($0.18)
Q3 20167($0.52)($0.20)($0.43)
Q4 20167($0.56)($0.21)($0.45)
Q1 20171($0.50)($0.50)($0.50)
Q2 20171($0.50)($0.50)($0.50)
Q3 20171($0.51)($0.51)($0.51)
Q4 20171($0.51)($0.51)($0.51)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aduro Biotech (NASDAQ:ADRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aduro Biotech (NASDAQ:ADRO)
Insider Ownership Percentage: 6.50%
Institutional Ownership Percentage: 29.76%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/19/2016Jennifer LewInsiderSell6,360$14.95$95,082.00View SEC Filing  
9/1/2016Thomas W DubenskyInsiderSell25,000$14.03$350,750.00View SEC Filing  
8/11/2016Thomas W DubenskyInsiderSell25,000$15.18$379,500.00View SEC Filing  
7/5/2016Thomas W DubenskyInsiderSell25,000$11.61$290,250.00View SEC Filing  
5/16/2016Thomas W. DubenskyInsiderSell905$8.20$7,421.00View SEC Filing  
1/11/2016Dirk G. BrockstedtVPSell22,000$21.77$478,940.00View SEC Filing  
1/8/2016Gregory W. SchaferCOOSell20,000$23.58$471,600.00View SEC Filing  
1/6/2016Jennifer LewVPSell5,242$25.71$134,771.82View SEC Filing  
1/5/2016Stephen T. IsaacsCEOSell25,000$26.31$657,750.00View SEC Filing  
1/4/2016Thomas W. DubenskyinsiderSell15,000$26.37$395,550.00View SEC Filing  
12/7/2015Gregory W. SchaferCOOSell25,000$29.74$743,500.00View SEC Filing  
12/3/2015Jennifer LewVPSell5,242$29.85$156,473.70View SEC Filing  
12/1/2015Stephen T. IsaacsCEOSell25,000$29.11$727,750.00View SEC Filing  
12/1/2015Thomas W. DubenskyinsiderSell30,000$29.27$878,100.00View SEC Filing  
11/18/2015Jennifer LewVPSell6,712$28.52$191,426.24View SEC Filing  
11/17/2015Gregory W. SchaferCOOSell26,470$28.15$745,130.50View SEC Filing  
11/17/2015Thomas W. DubenskyinsiderSell31,470$28.27$889,656.90View SEC Filing  
11/16/2015Stephen T. IsaacsCEOSell25,000$27.54$688,500.00View SEC Filing  
4/20/2015Jennifer LewVPBuy2,000$17.00$34,000.00View SEC Filing  
4/20/2015Venture (Vi) Inves MorningsideMajor ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing  
4/20/2015William Mariner GreenmanDirectorBuy3,000$17.00$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aduro Biotech (NASDAQ:ADRO)
DateHeadline
capitalcube.com logoAduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : September 26, 2016 (NASDAQ:ADRO)
www.capitalcube.com - September 26 at 3:17 PM
globenewswire.com logoAduro Biotech's Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce - GlobeNewswire (press release) (NASDAQ:ADRO)
www.globenewswire.com - September 26 at 8:41 AM
publicnow.com logoAduro Biotech’s Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce (NASDAQ:ADRO)
www.publicnow.com - September 26 at 8:41 AM
investornewswire.com logoShares Of Aduro BioTech Inc (NASDAQ:ADRO) Expected To Hit $22 - Investor Newswire (NASDAQ:ADRO)
www.investornewswire.com - September 25 at 3:39 PM
publicnow.com logoCoal India pushes into solar (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoIndonesia can apply ‘clean’ coal technology to reduce emissions (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoCoal Rises From Grave to Become One of Hottest Commodities (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoChina Seen Investing Too Much in Power Plants That Burn Coal (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoCoal Prices Surge Higher, But Could Retreat Soon As Production Caps Are Lifted (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoCoal’s cost advantage over LNG slipping, but not yet enough: Russell (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
publicnow.com logoChina Coal Control Jolts World Markets From Steel to Freight (NASDAQ:ADRO)
www.publicnow.com - September 23 at 8:07 AM
finance.yahoo.com logoAduro Biotech to Present at LEERINK Partners Roundtable Series - Yahoo Finance (NASDAQ:ADRO)
finance.yahoo.com - September 22 at 3:18 PM
publicnow.com logoAduro Biotech to Present at LEERINK Partners Roundtable Series (NASDAQ:ADRO)
www.publicnow.com - September 22 at 8:51 AM
News IconAduro BioTech Inc (NASDAQ:ADRO) Receives Consensus Rating of “Buy” from Brokerages - DailyQuint (NASDAQ:ADRO)
dailyquint.com - September 19 at 8:05 AM
investornewswire.com logoExpected For Aduro BioTech Inc (NASDAQ:ADRO) Sales Of $144.695 - Investor Newswire (NASDAQ:ADRO)
www.investornewswire.com - September 15 at 3:18 PM
biz.yahoo.com logoADURO BIOTECH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:ADRO)
biz.yahoo.com - September 14 at 8:35 PM
News IconAduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased 4.37% After Market Selling - Frisco Fastball (NASDAQ:ADRO)
friscofastball.com - September 14 at 3:18 PM
News IconShares Going Lower in Trade: Aduro BioTech, Inc. (NASDAQ:ADRO) - Post News (NASDAQ:ADRO)
www.kentuckypostnews.com - September 13 at 3:19 PM
capitalcube.com logoAduro BioTech, Inc. – Value Analysis (NASDAQ:ADRO) : September 13, 2016 (NASDAQ:ADRO)
www.capitalcube.com - September 13 at 3:19 PM
capitalcube.com logoAduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : September 12, 2016 (NASDAQ:ADRO)
www.capitalcube.com - September 12 at 3:19 PM
News IconPlacing Aduro BioTech Inc (NASDAQ:ADRO) Shares Under the Microscope - Post News (NASDAQ:ADRO)
www.kentuckypostnews.com - September 9 at 8:05 AM
publicnow.com logoChina’s Inner Mongolia cuts coal output by 10 pct in Jan-July (NASDAQ:ADRO)
www.publicnow.com - September 9 at 8:05 AM
publicnow.com logoThe Challenge of Cutting Coal Dependence (NASDAQ:ADRO)
www.publicnow.com - September 9 at 8:05 AM
News IconIntraday Active Biotech Stocks News: Aduro BioTech, Inc. (NASDAQ:ADRO), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar (NASDAQ:ADRO)
voiceregistrar.com - September 8 at 3:18 PM
News IconWhat are Brokerage Firms Saying About Aduro BioTech Inc (NASDAQ:ADRO)? - Frisco Fastball (NASDAQ:ADRO)
friscofastball.com - September 7 at 8:27 PM
News IconConsensus Analyst Thoughts for: Procter & Gamble Company (NYSE:PG) , Aduro Biotech, Inc. (NASDAQ:ADRO) - Wall Street Times (press release) (NASDAQ:ADRO)
www.wallstreetnews24.com - September 7 at 12:16 PM
News IconAttention Seekers of Biotechnology: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Aduro BioTech Inc (NASDAQ ... - Post Registrar (NASDAQ:ADRO)
postregistrar.com - September 7 at 12:16 PM
News IconNews review of 2 biotech stocks: Aduro BioTech, Inc. (NASDAQ:ADRO), CTI BioPharma Corp. (NASDAQ:CTIC) - The Voice Registrar (NASDAQ:ADRO)
voiceregistrar.com - September 6 at 3:18 PM
finance.yahoo.com logoAduro Biotech Appoints Oncology Expert and Industry Veteran Natalie Sacks, M.D. as Chief Medical Officer (NASDAQ:ADRO)
finance.yahoo.com - September 6 at 8:04 AM
bizjournals.com logoA 360-degree sneak peek: Inside Berkeley biotech's new building - San Francisco Business Times (blog) (NASDAQ:ADRO)
www.bizjournals.com - September 2 at 3:21 PM
globenewswire.com logoAduro Biotech Announces New Corporate Offices and Laboratory Space - GlobeNewswire (press release) (NASDAQ:ADRO)
globenewswire.com - September 2 at 5:28 AM
bizjournals.com logoA 360-degree sneak peek: Inside Berkeley biotech's new building (NASDAQ:ADRO)
feeds.bizjournals.com - September 1 at 6:33 PM
finance.yahoo.com logoAduro Biotech Announces New Corporate Offices and Laboratory Space - Yahoo Finance (NASDAQ:ADRO)
finance.yahoo.com - September 1 at 3:18 PM
News IconShares Slipping Lower Over the Past Month: Aduro BioTech, Inc. (NASDAQ:ADRO) - Post News (NASDAQ:ADRO)
www.kentuckypostnews.com - September 1 at 3:18 PM
publicnow.com logoAduro Biotech Announces New Corporate Offices and Laboratory Space (NASDAQ:ADRO)
www.publicnow.com - September 1 at 11:44 AM
capitalcube.com logoETF’s with exposure to Aduro BioTech, Inc. : August 30, 2016 (NASDAQ:ADRO)
www.capitalcube.com - August 30 at 12:18 PM
capitalcube.com logoAduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : August 29, 2016 (NASDAQ:ADRO)
www.capitalcube.com - August 29 at 3:45 PM
publicnow.com logo1H16 Financial Press Release (NASDAQ:ADRO)
www.publicnow.com - August 29 at 3:45 PM
investornewswire.com logoAduro BioTech Inc (NASDAQ:ADRO) Gets 1 Recommendations To ... - Investor Newswire (NASDAQ:ADRO)
www.investornewswire.com - August 29 at 8:04 AM
News IconBest Biotech Stocks: This $15 Biotech Stock is About to Go Vertical (NASDAQ:ADRO)
www.profitconfidential.com - August 26 at 11:25 AM
publicnow.com logoPTBA Acquires Ignite Resources to Increase Efficiency (NASDAQ:ADRO)
www.publicnow.com - August 26 at 11:25 AM
publicnow.com logoChinese July thermal coal imports jump 31% on year to 19-month high (NASDAQ:ADRO)
www.publicnow.com - August 26 at 11:25 AM
publicnow.com logoVietnam’s July coal imports surge 141% on year to 1.31 million mt (NASDAQ:ADRO)
www.publicnow.com - August 23 at 9:33 AM
publicnow.com logoMetallurgical coal poised for biggest weekly price surge since 2011 Queensland floods (NASDAQ:ADRO)
www.publicnow.com - August 23 at 9:33 AM
investornewswire.com logoWill Aduro BioTech Inc (NASDAQ:ADRO) Hit $22 Price Target? - Investor Newswire (NASDAQ:ADRO)
www.investornewswire.com - August 22 at 8:06 AM
News IconHow is the Crowd Rating Shares of Aduro BioTech Inc (NASDAQ:ADRO)? - Post News (NASDAQ:ADRO)
www.kentuckypostnews.com - August 19 at 3:34 PM
publicnow.com logoU.S. coal use may rise, but unlikely to unseat natgas as power king (NASDAQ:ADRO)
www.publicnow.com - August 19 at 11:33 AM
publicnow.com logoChina’s Coal-Market Reforms Fuel Rebound in Prices (NASDAQ:ADRO)
www.publicnow.com - August 19 at 11:33 AM
investornewswire.com logoAnalysts See Sales Of $144.695 For Aduro BioTech Inc (NASDAQ:ADRO) - Investor Newswire (NASDAQ:ADRO)
www.investornewswire.com - August 17 at 8:50 PM
publicnow.com logoChina steel, coal companies jump on debt-to-equity swap proposals (NASDAQ:ADRO)
www.publicnow.com - August 16 at 11:55 AM

Social

Aduro Biotech (NASDAQ:ADRO) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff